Sage Journals: Discover world-class research

Abstract

This commentary provides an overview of the Association of Multidisciplinary Education and Research in Substance use and Addiction (AMERSA) 2021 annual conference: Transforming Care Through Evidence and Policy. The topics covered during the conference were especially critical given the unprecedented rise in drug overdose deaths and continued impact of the COVID-19 pandemic on substance use and addiction. The importance of tackling stigma and ensuring that we partner with those with lived experience to have maximal impact was highlighted.

Keywords

Multidisciplinary stigma lived experience evidence policy addiction

Get full access to this article

View all access options for this article.

References

Ahmad

, Rossen

, Sutton

Provisional drug overdose death counts. National Center for Health Statistics. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm. Published 2021. Accessed April 9, 2021.

Gramlich

Recent surge in U.S. drug overdose deaths has hit Black men the hardest. Pew Research Center. https://www.pewresearch.org/fact-tank/2022/01/19/recent-surge-in-u-s-drug-overdose-deaths-has-hit-black-men-the-hardest/. Published January 19, 2022.

Hall

, Trimble

, Garcia

, Entrup

, Deaner

, Teater

Unintentional drug overdose mortality in years of life lost among adolescents and young people in the US from 2015 to 2019. JAMA Pediatr. 2022;176(4):415–417.

Wang

, Weiss

, Ryan

, Waldman

, Rubin

, Griffin

JL.

Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic. J Subst Abuse Treat. 2021;124:108272.

Methadone Take-Home Flexibilities Extension Guidance. SAMHSA substance abuse and mental health services administration. https://www.samhsa.gov/medication-assisted-treatment/statutes-regulations-guidelines/methadone-guidance. Published March 3, 2022.

Edward

To Authorize a Study on Certain Exemptions for Treatment of Opioid Use Disorder through Opioid Treatment Programs during the COVID–19 Public Health Emergency, and for Other Purposes; 2022. https://www.markey.senate.gov/imo/media/doc/opioid_treatment_access_act.pdf

Avena

, Simkus

, Lewandowski

, Gold

, Potenza

MN.

Substance use disorders and behavioral addictions during the COVID-19 pandemic and COVID-19-related restrictions. Front Psychiatry. 2021;12:653674.

Czeisler

MÉ

, Lane

, Petrosky

et al. Mental health, substance use, and suicidal ideation during the COVID-19 Pandemic – United States, June 24–30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(32):1049–1057.

Jones

, Bekheet

, Park

, Alexander

GC.

The evolving overdose epidemic: synthetic opioids and rising stimulant-related harms. Epidemiol Rev. 2020;42(1):154–166.

10.

Ciccarone

The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Curr Opin Psychiatry. 2021;34(4):344–350.

11.

Increase in Fatal Drug Overdoses Across the United States Driven by Synthetic Opioids Before and During the COVID-19 Pandemic. 8. Centers for Disease Control and Prevention Health Alert Network Health Advisory. https://emergency.cdc.gov/han/2020/han00438.asp. Published December 17, 2020.

12.

Han

, Compton

, Jones

, Einstein

, Volkow

ND.

Methamphetamine use, methamphetamine use disorder, and associated overdose deaths among US adults. JAMA Psychiatry. 2021;78(12):1329.

13.

Venniro

, Zhang

, Caprioli

Volitional social interaction prevents drug addiction in rat models. Nat Neurosci. 2018;21(11):1520–1529.

14.

Hagle

, Martin

, Winograd

Dismantling racism against Black, Indigenous, and people of color across the substance use continuum: a position statement of the association for multidisciplinary education and research in substance use and addiction. Subst Abus. 2021;42(1):5–12.

15.

Broyles

, Binswanger

, Jenkins

Confronting inadvertent stigma and pejorative language in addiction scholarship: a recognition and response. Subst Abus. 2014;35(3):217–221.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.26 MB

Commentary Article: Association of Multidisciplinary Education and Research in Substance use and Addiction's (AMERSA) 2021 Transforming Care through Evidence and Policy Conference: Tackling Stigma and Giving Voice to Lived Experience

Abstract

Keywords

Get full access to this article

References

Supplementary Material